Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
Journal article
Shankar-Hari M. et al, (2021), JAMA
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter-2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter-2 inhibitors
Journal article
HERRINGTON W. et al, (2021), European Journal of Heart Failure
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None. et al, (2021)
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Dexamethasone in hospitalized patients with covid-19
Journal article
Horby P. et al, (2021), New England Journal of Medicine, 384, 693 - 704
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None. et al, (2021)
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby P. et al, (2020)
taleNeprilysin and Neprilysin inhibition in chronic kidney disease.
Journal article
Judge PK. and Haynes R., (2020), Curr Opin Nephrol Hypertens
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article
Zhu P. et al, (2020), J Am Soc Nephrol
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.
Effect of hydroxychloroquine in hospitalized patients with COVID-19
Journal article
LANDRAY M. and HORBY P., (2020), New England Journal of Medicine
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2020), Lancet
International consensus definitions of clinical trial outcomes for kidney failure: 2020
Journal article
Levin A. et al, (2020), Kidney International, 98, 849 - 859
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article
HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Journal article
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
Journal article
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2020), JAMA